Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report.
Sachiyo OnishiMasahiro TajikaHideaki BandoYuki MatsubaraWaki HosodaKei MuroYasumasa NiwaPublished in: Journal of medical case reports (2020)
Ursodeoxycholic acid and bezafibrate may be useful for treatment of steroid-refractory immune-related adverse event hepatitis.
Keyphrases